Project Grant R43DA062975
Award Date
5/15/25
Completion Date
4/30/26
Dollars Obligated
$399K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
미국 뉴욕
Similar Awards
This $397,829 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of an AI platform to accelerate the discovery of therapeutics for substance use disorders (SUDs). The key objectives of this 1-year project are to: 1) create curated datasets and machine learning models to expedite drug discovery tasks, 2) identify mechanistic targets for GLP-1 receptor agonist pathways that can...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to discover novel small molecule therapeutics for the safe and effective treatment of opioid use disorder (OUD). The $399,414 award will fund the development of an AI-powered platform called M3.AI that integrates target-based and phenotype-based drug discovery methodologies. The platform will generate multi-cell type, multi-objective,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to identify small molecule compounds that can bind to the GPR26 receptor and potentially treat opioid use disorders (OUDs) without directly targeting opioid receptors. The $399,884 award to Jillion Therapeutics Inc. will utilize DNA-encoded library (DEL) screening technology to test over 125 million proprietary compounds for high-affinity...
This $134,311 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a 5-year "Preparing the Next Generation of Addiction Researchers in Computational AI/ML Techniques" research education program. The program aims to train 8-10 predoctoral and postdoctoral trainees per year in statistical machine learning (SML) and artificial intelligence (AI) techniques applicable to addiction research. Key...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $398,137 to Boston Interactome LLC to develop high-precision epigenetic therapeutics for opioid use disorder (OUD). The project aims to identify small-molecule compounds that can selectively modulate the G9A protein complex, which regulates the expression of DFosB in the brain during chronic opioid exposure. The work will involve a...
The National Institute on Drug Abuse (NIDA) awarded a $257,522 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of Mississippi to establish a "Multimodal and Interdisciplinary Data Science Training Program to Enhance a Diverse Workforce for Addiction Research." The program aims to address the lack of specialized training in artificial intelligence (AI) and machine learning (ML) methods for addiction research in Mississippi's major universities....
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $284,040 to the Lieber Institute for Brain Development to conduct research on the molecular mechanisms underlying opioid addiction. The project aims to use integrated single-cell and spatial transcriptomic approaches to map gene expression changes in specific cell populations and projection neurons within the habenula, a key brain region...
This Project Grant award of $800,617 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development and validation of neuromarkers - measurable, brain-based indicators of pathophysiology, risk, and resilience related to substance use disorders (SUDs). The key objectives are to build upon prior research (R01DA043690) that used machine learning and fMRI data to create a cross-validated neuromarker for drug craving, a...
This Project Grant award of $847,000 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the neuropeptide S receptor 1 (NPSR1) as a potential target for reducing opioid self-administration and relapse in opioid use disorder. The research aims to evaluate whether NPSR1 agonism can alleviate the anxious phenotype observed during opioid withdrawal, which contributes to the intensified motivation to seek...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $136,320.00 to Wake Forest University Health Sciences to develop and disseminate a scalable education intervention for advancing data science skills in addiction research. The key products to be delivered include: An immersive, tailored addiction data science skills course that provides hands-on training in FAIR (findable, accessible,...